rs10810657

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

basal cell carcinoma

Allele A
OR 1.10
p 1.0e-35
N 812,765
Meta-analysisLarge GWAS
multi-ancestry
Liyanage UE et al. Combined analysis of keratinocyte cancers identifies novel genome-wide loci. Human Molecular Genetics 28(18):3148-3160 (2019)
Allele A
OR 1.10
p 4.0e-26
N 651,138
Large GWAS
European
Allele A
OR 1.11
p 2.0e-17
N 275,209
Large GWAS
European

low density lipoprotein cholesterol measurement

Allele T
OR 0.02
p 5.0e-20
N 431,167
Major Consortium StudyLarge GWAS
European
Allele T
OR 0.01
p 9.0e-12
N 928,679
Large GWAS
multi-ancestry

cutaneous squamous cell carcinoma

Allele T
OR 0.10
p 1.0e-17
N 699,198
Meta-analysisLarge GWAS
European
Allele T
OR 1.11
p 6.0e-17
N 778,893
Meta-analysisLarge GWAS
European
Allele T
OR 1.11
p 1.0e-8
N 287,137
Large GWAS
European

squamous cell carcinoma

Liyanage UE et al. Combined analysis of keratinocyte cancers identifies novel genome-wide loci. Human Molecular Genetics 28(18):3148-3160 (2019)
Allele A
OR 1.13
p 8.0e-15
N 635,331
Large GWAS
European

eosinophil count

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.02
p 5.0e-12
N 408,112
Large GWAS
European

eosinophil percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.02
p 5.0e-11
N 408,112
Large GWAS
European

total cholesterol measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele A
OR 0.02
p 1.0e-9
N 355,858
Major Consortium StudyLarge GWAS
multi-ancestry

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…